Nebu~Flow is a Glasgow-based medtech company advancing next-generation respiratory drug delivery, combining deep engineering and scientific expertise to address unmet clinical needs. Backed by over £4.7 million in seed funding and recognised with awards including the 2024 CPHI Pharma Start-Up Initiative, Nebu~Flow is scaling internationally to commercialise its nebuliser technology and deliver investor value in the global inhalation therapeutics market.
